APMD
APMD clinical trials: Apnimed, Inc.
Every trial on ClinicalTrials.gov where Apnimed, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 19
- Trials linked
- 13
- As lead sponsor
- 6
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
APMD on the catalyst calendar · APMD registry changes
- Primary completion May 7, 2025ActualPhase 3NCT05811247Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)Apnimed · OSACompletedAPMDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 10, 2025ActualPhase 3NCT05813275Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)Apnimed · OSACompletedAPMDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 20, 2022ActualPhase 2NCT05071612Parallel Arm Trial of AD109 and AD504 In Patients With OSAApnimed · OSA - Obstructive Sleep ApneaCompletedAPMDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 30, 2026Sponsor estimatePhase 3NCT06566820Continuation Protocol for Obstructive Sleep Apnea (OSA)Apnimed · OSAEnrolling by invitationAPMDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 26, 2024ActualPhase 2NCT06400615Study That Tests AD109 in Patients Taking GLP-1 DrugsApnimed · OSACompletedAPMDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 9, 2023ActualPhase 2NCT05793684AD816 Crossover StudyApnimed · OSACompletedAPMDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 1, 2020ActualPhase 2NCT04445688Crossover Trial of AD036 in Obstructive Sleep ApneaApnimed · Obstructive Sleep ApneaCompletedAPMDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 31, 2023ActualPhase 2NCT04905979Trial of AD113 and Atomoxetine in OSA Patients With HypertensionApnimed · Obstructive Sleep ApneaCompletedAPMDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 18, 2022ActualPhase 1/Phase 2NCT05101122Study for Efficacy and Dose Escalation of AD313 + Atomoxetine (SEED)Apnimed · Obstructive Sleep ApneaCompletedAPMDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 28, 2021ActualPhase 2NCT04580394Crossover Trial of AD109 in Obstructive Sleep ApneaApnimed · Obstructive Sleep ApneaCompletedAPMDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 23, 2019ActualPhase 2NCT03845023Trial of AD036 in Obstructive Sleep ApneaApnimed · Obstructive Sleep ApneaCompletedAPMDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 31, 2021ActualPhase 2NCT04631107AD109 Dose Finding in Mild to Moderate OSAApnimed · Obstructive Sleep ApneaCompletedAPMDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 1, 2021ActualPhase 2NCT04645524Crossover Trial of AD182 and AD504 in Obstructive Sleep ApneaApnimed · Obstructive Sleep ApneaCompletedAPMDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 8, 2024ActualPhase 2NCT05448443Study of AD981 Versus Placebo in Obesity Hypoventilation SyndromeIstituto Auxologico Italiano · Obesity Hypoventilation Syndrome (OHS)CompletedAPMDCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 29, 2024Sponsor estimateNo phase registeredNCT06525337Adherence to Health Coaching with Wearable Devices: Enhancing Patient Engagement and OutcomesCoastal Carolina University · Obstructive Sleep ApneaUnknown statusAPMDCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 18, 2022ActualPhase 2NCT04611750Pharmacological Intervention for Symptomatic Mild Sleep Disordered BreathingBrigham and Women's Hospital · Sleep Disordered BreathingCompletedAPMDCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 3, 2021ActualPhase 1/Phase 2NCT03892772Combination Pharmacological Interventions for Multiple Mechanisms of Obstructive Sleep ApneaBrigham and Women's Hospital · Sleep ApneaCompletedAPMDCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 30, 2020ActualPhase 2NCT04449133Study of AD128 Versus Placebo in Obstructive Sleep ApneaIstituto Auxologico Italiano · Obstructive Sleep ApneaCompletedAPMDCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 19, 2021ActualPhase 2/Phase 3NCT04394143Effect of AD128 to Treat Obstructive Sleep ApneaRaphael Heinzer · Sleep Apnea, ObstructiveCompletedAPMDCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 19 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner